ArticleERJ open research2026
Genetic variants underpinning lung function decline in the Lifelines general population cohort study.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: Variations in age-related lung function decline are associated with genetic and environmental factors. The genetic variants contributing to this decline remain largely unknown, limiting the understanding of individual susceptibility and potential interventions. This study aims to uncover the genetic factors associated with lung function decline, using the Lifelines cohort study. Methods: Longitudinal data covering three visits over approximately 15 years were available. Genotyping and longitudinal spirometry data were present for 24 749 subjects aged 25 years or older at baseline. A three-step approach was used. First, lung function change over time was estimated using a linear mixed-effects model. Second, a genome-wide association study for the estimated change was conducted, adjusting for age, sex, smoking load and the first 10 principal components. Third, single-nucleotide polymorphisms (SNPs) with p-value<1×10 Measurements and main results: Among the included individuals, 19 722 had spirometry at two time points and 5027 at three, with median (IQR) follow-up of 8.1 (4.4-10.4) and 12.1 (11-13.6) years, respectively. We identified 67 variants suggestively associated with lung function decline (p<1×10 Conclusions: This study shows a role of genetics in lung function decline, emphasising the importance of exploring the interplay between genetic and environmental factors.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.